Zevra Therapeutics, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Zevra Therapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2024-09-30 was 10.62M shares.
- Zevra Therapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2019-09-30 was 1.20M shares, a 776.73% increase year-over-year.
- Zevra Therapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2018-09-30 was 136.87K shares.
- Zevra Therapeutics, Inc. stock issued during period, shares, new issues for the quarter ending 2018-06-30 was 179.35K shares.
- Zevra Therapeutics, Inc. stock issued during period, shares, new issues for fiscal 2024 was 10.62M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2024-12-31 | 10.62M shares 10-K · filed 2026-03-09 | |
| 2024-09-30 | 10.62M shares 10-Q · filed 2024-11-13 | |
| 2019-09-30 | 1.20M shares 10-Q · filed 2019-11-14 | |
| 2018-09-30 | 136.87K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | |
| 2018-06-30 | 179.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | |
| 2018-03-31 | 446.11K shares 10-Q · filed 2018-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |